Fri, November 11, 2022
Thu, November 10, 2022
Wed, November 9, 2022

Drew Ranieri Maintained (BVS) at Buy with Decreased Target to $5 on, Nov 10th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-5-on-nov-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Drew Ranieri of Morgan Stanley, Maintained "Bioventus Inc." (BVS) at Buy with Decreased Target from $11 to $5 on, Nov 10th, 2022.

Drew has made no other calls on BVS in the last 4 months.



There are 3 other peers that have a rating on BVS. Out of the 3 peers that are also analyzing BVS, 2 agree with Drew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Kyle Rose of "Canaccord Genuity" Downgraded from Strong Buy to Hold on, Wednesday, November 9th, 2022
  • Amit Hazan of "Goldman Sachs" Maintained at Hold with Decreased Target to $13 on, Wednesday, September 7th, 2022


This is the rating of the analyst that currently disagrees with Drew


  • Robbie Marcus of "JP Morgan" Downgraded from Buy to Sell on, Wednesday, November 9th, 2022

Publication Contributing Sources